跳至主要内容
临床试验/NCT04710160
NCT04710160Unknown不适用

Clinical and Radiographic Evaluation in Pulpotomy of Primary Molars Using Novel Fast-setting Calcium Silicate Cement (Protooth) Versus Mineral Trioxide Aggregate (MTA): A Pilot Study

Cairo University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2021年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
Clinical evaluation including postoperative pain , pain on percussion or palpation will be measured using VAS

研究概览

简要总结

The aim of the study is to evaluate the clinical and radiographic success in pulpotomy using novel fast-setting calcium silicate cement (Protooth) versus MTA in exposed primary molars.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
4 Years 至 8 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Complete physical and mental health, with no confounding history of systemic disease and/or use of special local or systemic drugs
  • No allergic reactions recorded in patient history
  • Having primary molar teeth in one jaw, having deep caries and vital pulp.
  • No history of spontaneous pain, pathologic mobility, draining sinus tract, redness or swelling of vestibule
  • Normal gingival and periodontal condition, with no sensitivity to vestibular palpation, and no pain on percussion test
  • Radiographic criteria:
  • No sign of radiolucency in periapical or furcation area
  • No widening of PDL space or loss of lamina dura continuity
  • No evidence of internal/external pathologic root resorption

排除标准

  • Lack of informed consent by the child patient's parent
  • Lack of informed consent by the child patient's parent
  • Unable to attend follow-up visits.
  • Refusal of participation.

研究组 & 干预措施

Novel fast setting calcium silicate ( Protooth)

Active Comparator

In the form of powder and liquid to be mixed together to form paste.

干预措施: Novel fast-setting calcium silicate cement (Protooth) (Drug)

MTA

Experimental

In form of powder to be mixed with saline to form paste.

干预措施: Novel fast-setting calcium silicate cement (Protooth) (Drug)

结局指标

主要结局

Clinical evaluation including postoperative pain , pain on percussion or palpation will be measured using VAS

时间窗: 12 months

Post-operative pain following pulpotomy treatment will be measured. A pain chart using visual analogue scale (VAS) will be used to record the patients' pain levels. The VAS (0-10 scale) consists of a line anchored by two extremes "No pain" and "the worst pain". Patients will be asked to choose the mark that represented their level of pain from 0 to 10. Pain level will be assigned as follow: 0, "no pain" 1-3, "mild pain" 4-6, "moderate pain" 7-10, "severe pain" Using the VAS chart, the patient will choose and record the most appropriate pain rating according to the pain intensity endured.

次要结局

  • Radiographic evaluation following the Pulpotomy treatment will be measured(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nashwa Ossama Ahmed Elshaer

principle investigator

Cairo University

研究点 (1)

Loading locations...

相似试验